Navneet Kaur

FDA investigator

Appears on 5 documents from 2024 to 2026, mostly at sites in California. Most often cites testing and approval or rejection of components, drug product containers, and closures (21 CFR 211.84(d)(1)).

5
Documents on file
6.8
Observations per 483
2024
First seen
2026
Most recent

What they cite most

From 34 observations

Activity by year

2024: 1, 2025: 2, 2026: 2

Where

California 4 · Washington 1

Is Navneet Kaur coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Dr. J Skinclinic, IncMar 23, 2026 · Cerritos, California
Amended 483 Pyramid Laboratories, IncFeb 13, 2026 · Costa Mesa, California
483 Sparsha Pharma Usa IncSep 4, 2025 · Oceanside, California
483 Soaptronic LLCApr 28, 2025 · LAKE FOREST, California
483 Silgan Unicep Packaging LieJun 14, 2024 · Spokane, Washington

About this profile

What does Navneet Kaur inspect?

Navneet Kaur appears on 5 documents on file covering 5 sites, mostly in California.

What do they cite most often?

21 CFR 211.84(d)(1) (testing and approval or rejection of components, drug product containers, and closures), followed by 21 CFR 211.160(a) and 21 CFR 211.165(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Navneet Kaur is dated Mar 23, 2026.